The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market weakness. The S&P BSE Healthcare index stood at 42,126.64, down 0.90%, while the Nifty 50 was at 25,434.10, lower by 0.59%. The BSE Sensex was at 82,867.76, down 0.45%.
Most listed pharma scrips showed negative movement in early trade:
- Aarti Drugs: BSE ₹374.80 (-0.50%), NSE ₹373.80 (-0.72%)
- Ajanta Pharma: BSE ₹2,665.70 (-0.83%), NSE ₹2,676.60 (-0.34%)
- Alembic Pharma: BSE ₹766.50 (-0.48%), NSE ₹763.00 (-0.88%)
- Aurobindo Pharma: BSE ₹1,159.50 (-0.66%), NSE ₹1,153.00 (-1.25%)
- Biocon: BSE ₹370.20 (-1.54%), NSE ₹369.85 (-1.65%)
- Cipla: BSE ₹1,386.35 (-0.35%), NSE ₹1,382.60 (-0.70%)
- Divi’s Laboratories: BSE ₹6,113.95 (-0.44%), NSE ₹6,098.00 (-0.68%)
- Dr. Reddy’s Lab: BSE ₹1,164.85 (-0.14%), NSE ₹1,161.60 (-0.48%)
- Glenmark Pharma: BSE ₹1,965.00 (-1.29%), NSE ₹1,962.30 (-1.38%)
- Indoco Remedies: BSE ₹211.95 (-1.03%), NSE ₹212.90 (-0.39%)
- Ipca Labs: BSE ₹1,478.45 (-0.65%), NSE ₹1,474.80 (-0.83%)
- J.B. Chemicals: BSE ₹1,907.45 (-1.09%), NSE ₹1,904.90 (-1.13%)
- Lupin: BSE ₹2,162.00 (-0.74%), NSE ₹2,158.50 (-0.85%)
- Mankind Pharma: BSE ₹2,091.55 (-1.24%), NSE ₹2,088.80 (-1.34%)
- Natco Pharma: BSE ₹839.40 (-0.69%), NSE ₹838.50 (-0.86%)
- Orchid Pharma: BSE ₹705.00 (-0.73%), NSE ₹704.80 (-0.99%)
- Panacea Biotech: BSE ₹393.00 (+0.24%), NSE ₹391.65 (0.00%) — one of the few with flat to positive change
- Strides Pharma Science: BSE ₹880.70 (+1.30%), NSE ₹877.25 (+0.94%) — positive movement
- Sudeep Pharma Ltd.: BSE ₹551.90 (-2.06%), NSE ₹548.00 (-2.59%)
- Sun Pharma: BSE ₹1,660.00 (-0.81%), NSE ₹1,660.80 (-0.87%)
- Torrent Pharma: BSE ₹4,048.00 (-1.05%), NSE ₹4,037.50 (-1.20%)
- Wockhardt: BSE ₹1,409.05 (-0.63%), NSE ₹1,401.00 (-1.17%)
- Zydus Lifesciences: BSE ₹881.90 (+0.09%), NSE ₹879.60 (-0.17%)
Declines ranged from minor (under 0.5%) to more notable (over 1-2% in cases like Sudeep Pharma, Biocon, and Glenmark). A few counters, such as Strides Pharma Science and Panacea Biotech, bucked the trend with gains or stability.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
